Cited by 36DNA Repair MechanismsGenomics and Chromatin DynamicsChromatin Remodeling and Cancer

Double duty: ZMYND8 in the DNA damage response and cancer

Open access
Gong, Fade, Miller, Kyle M.·2018·Cell Cycle

Abstract

Our genetic information is organized into chromatin, which consists of histones and proteins involved in regulating DNA compaction, accessibility and function. Chromatin is decorated by histone modifications, which provide signals that coordinate DNA-based processes including transcription and DNA damage response (DDR) pathways. A major signal involved in these processes is acetylation, which when attached to lysines within proteins, including histones, can be recognized and read by bromodomain-containing proteins. We recently identified the bromodomain protein ZMYND8 (also known as RACK7 and PRKCBP1) as a critical DNA damage response factor involved in regulating transcriptional responses and DNA repair activities at DNA double-strand breaks. Other studies have further defined the molecular details for how ZMYND8 interacts with chromatin and other chromatin modifying proteins to exert its DNA damage response functions. ZMYND8 also plays essential roles in regulating transcription during normal cellular growth, perturbation of which promotes cellular processes involved in cancer initiation and progression. In addition to acetylation, histone methylation and demethylase enzymes have emerged as important regulators of ZMYND8. Here we discuss our current understanding of the molecular mechanisms that govern ZMYND8 function within chromatin, highlighting the importance of this protein for genome maintenance both during the DDR and in cancer.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/15384101.2017.1376150

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 68

  1. Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature. 2009;461:1071-8. doi:10.1038/nature08467. PMID:19847258 · DOI · Paper page
  2. Ciccia A, Elledge SJ. The DNA damage response: making it safe to play with knives. Mol Cell. 2010;40:179-204. doi:10.1016/j. molcel.2010.09.019. PMID:20965415 · DOI · Paper page
  3. Miller KM, Jackson SP. Histone marks: repairing DNA breaks within the context of chromatin. Biochem Soc Trans. 2012;40:370-6. doi:10.1042/BST20110747. PMID:22435814 · DOI
  4. Jackson SP, Durocher D. Regulation of DNA damage responses by ubiquitin and SUMO. Mol Cell. 2013;49:795-807. doi:10.1016/j. molcel.2013.01.017. PMID:23416108 · DOI · Paper page
  5. Gong F, Miller KM. Mammalian DNA repair: HATs and HDACs make their mark through histone acetylation. Mutat Res. 2013;750:23- 30. doi:10.1016/j.mrfmmm.2013.07.002. PMID:23927873 · DOI
  6. Gong F, Chiu LY, Miller KM. Acetylation reader proteins: linking acetylation signaling to genome maintenance and cancer. PLoS Genet. 2016;12:e1006272. doi:10.1371/journal.pgen.1006272. PMID:27631103 · DOI
  7. Agarwal P, Miller KM. The nucleosome: orchestrating DNA damage signaling and repair within chromatin. Biochem Cell Biol. 2016;94:381-95. doi:10.1139/bcb-2016-0017. PMID:27240007 · DOI
  8. Polo SE, Jackson SP. Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications. Genes Dev. 2011;25:409-33. doi:10.1101/gad.2021311. PMID:21363960 · DOI · Paper page
  9. Negrini S, Gorgoulis VG, Halazonetis TD. Genomic instability-an evolving hallmark of cancer. Nat Rev Mol Cell Biol. 2010;11:220-8. doi:10.1038/nrm2858. PMID:20177397 · DOI · Paper page
  10. Suganuma T, Workman JL. Signals and combinatorial functions of histone modifications. Annu Rev Biochem. 2011;80:473-99. doi:10.1146/annurev-biochem-061809-175347. PMID:21529160 · DOI
  11. Kouzarides T. Chromatin modifications and their function. Cell. 2007;128:693-705. doi:10.1016/j.cell.2007.02.005. PMID:17320507 · DOI · Paper page
  12. Weake VM, Workman JL. Histone ubiquitination: triggering gene activity. Mol Cell. 2008;29:653-63. doi:10.1016/j.molcel.2008.02.014. PMID:18374642 · DOI
  13. Polo SE, Almouzni G. DNA damage leaves its mark on chromatin. Cell Cycle. 2007;6:2355-9. doi:10.4161/cc.6.19.4756. PMID:17703111 · DOI
  14. Shahbazian MD, Grunstein M. Functions of site-specific histone acetylation and deacetylation. Annu Rev Biochem. 2007;76:75-100. doi:10.1146/annurev.biochem.76.052705.162114. PMID:17362198 · DOI · Paper page
  15. Ruthenburg AJ, Li H, Patel DJ, et al. Multivalent engagement of chromatin modifications by linked binding modules. Nat Rev Mol Cell Biol. 2007;8:983-94. doi:10.1038/nrm2298. PMID:18037899 · DOI
  16. Musselman CA, Lalonde ME, Cote J, et al. Perceiving the epigenetic landscape through histone readers. Nat Struct Mol Biol. 2012;19:1218-27. doi:10.1038/nsmb.2436. PMID:23211769 · DOI
  17. Xu Y, Price BD. Chromatin dynamics and the repair of DNA double strand breaks. Cell Cycle. 2011;10:261-7. doi:10.4161/cc.10.2.14543. PMID:21212734 · DOI
  18. Seeber A, Dion V, Gasser SM. Remodelers move chromatin in response to DNA damage. Cell Cycle. 2014;13:877-8. doi:10.4161/ cc.28200. PMID:24552812 · DOI
  19. Rogakou EP, Pilch DR, Orr AH, et al. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem. 1998;273:5858-68. doi:10.1074/jbc.273.10.5858. PMID:9488723 · DOI · Paper page
  20. Stucki M, Clapperton JA, Mohammad D, et al. MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell. 2005;123:1213-26. doi:10.1016/j. cell.2005.09.038. PMID:16377563 · DOI
  21. Botuyan MV, Lee J, Ward IM, et al. Structural basis for the methyla- tion state-specific recognition of histone H4-K20 by 53BP1 and Crb2 in DNA repair. Cell. 2006;127:1361-73. doi:10.1016/j.cell.2006.10.043. PMID:17190600 · DOI
  22. Fradet-Turcotte A, Canny MD, Escribano-Diaz C, et al. 53BP1 is a reader of the DNA-damage-induced H2A Lys 15 ubiquitin mark. Nature. 2013;499:50-4. doi:10.1038/nature12318. PMID:23760478 · DOI · Paper page
  23. Dawson MA, Kouzarides T, Huntly BJ. Targeting epigenetic readers in cancer. N Engl J Med. 2012;367:647-57. doi:10.1056/ NEJMra1112635. PMID:22894577 · DOI
  24. Fujisawa T, Filippakopoulos P. Functions of bromodomain-containing proteins and their roles in homeostasis and cancer. Nat Rev Mol Cell Biol. 2017;18:246-62. doi:10.1038/nrm.2016.143. PMID:28053347 · DOI
  25. Filippakopoulos P, Picaud S, Mangos M, et al. Histone recognition and large-scale structural analysis of the human bromodomain family. Cell. 2012;149:214-31. doi:10.1016/j.cell.2012.02.013. PMID:22464331 · DOI
  26. Filippakopoulos P, Knapp S. The bromodomain interaction module. FEBS Lett. 2012;586:2692-704. doi:10.1016/j.febslet.2012.04.045. PMID:22710155 · DOI
  27. Muller S, Filippakopoulos P, Knapp S. Bromodomains as therapeutic targets. Expert Rev Mol Med. 2011;13:e29. doi:10.1017/ S1462399411001992. PMID:21933453 · DOI
  28. Barbieri I, Cannizzaro E, Dawson MA. Bromodomains as therapeutic targets in cancer. Brief Funct Genomics. 2013;12:219-30. doi:10.1093/bfgp/elt007. PMID:23543289 · DOI
  29. Zhang G, Smith SG, Zhou MM. Discovery of Chemical Inhibitors of Human Bromodomains. Chem Rev. 2015;115:11625-68. doi:10.1021/acs.chemrev.5b00205. PMID:26492937 · DOI
  30. Filippakopoulos P, Qi J, Picaud S, et al. Selective inhibition of BET bromodomains. Nature. 2010;468:1067-73. doi:10.1038/nature09504. PMID:20871596 · DOI · Paper page
  31. Dawson MA, Prinjha RK, Dittmann A, et al. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature. 2011;478:529-33. doi:10.1038/nature10509. PMID:21964340 · DOI
  32. Andrieu G, Belkina AC, Denis GV. Clinical trials for BET inhibitors run ahead of the science. Drug Discov Today Technol. 2016;19:45- 50. doi:10.1016/j.ddtec.2016.06.004. PMID:27769357 · DOI · Paper page
  33. Boi M, Gaudio E, Bonetti P, et al. The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Mod- els and Synergizes with Targeted Drugs. Clin Cancer Res. 2015;21:1628- 38. doi:10.1158/1078-0432.CCR-14-1561. PMID:25623213 · DOI
  34. Adhikary S, Sanyal S, Basu M, et al. Selective Recognition of H3.1K36 Dimethylation/H4K16 Acetylation Facilitates the Regula- tion of All-trans-retinoic Acid (ATRA)-responsive Genes by Putative Chromatin Reader ZMYND8. J Biol Chem. 2016;291:2664-81. doi:10.1074/jbc.M115.679985. PMID:26655721 · DOI
  35. Li N, Li Y, Lv J, et al. ZMYND8 Reads the Dual Histone Mark H3K4me1-H3K14ac to Antagonize the Expression of Metastasis- Linked Genes. Mol Cell. 2016;63:470-84. doi:10.1016/j. molcel.2016.06.035. PMID:27477906 · DOI · Paper page
  36. Savitsky P, Krojer T, Fujisawa T, et al. Multivalent Histone and DNA Engagement by a PHD/BRD/PWWP Triple Reader Cassette Recruits ZMYND8 to K14ac-Rich Chromatin. Cell Rep. 2016;17:2724-37. doi:10.1016/j.celrep.2016.11.014. PMID:27926874 · DOI
  37. Spruijt CG, Luijsterburg MS, Menafra R, et al. ZMYND8 Co-localizes with NuRD on Target Genes and Regulates Poly(ADP-Ribose)- Dependent Recruitment of GATAD2A/NuRD to Sites of DNA Dam- age. Cell Rep. 2016;17:783-98. doi:10.1016/j.celrep.2016.09.037. PMID:27732854 · DOI
  38. Gong F, Clouaire T, Aguirrebengoa M, et al. Histone demethylase KDM5A regulates the ZMYND8-NuRD chromatin remodeler to promote DNA repair. J Cell Biol. 2017;216:1959-74. doi:10.1083/ jcb.201611135. PMID:28572115 · DOI
  39. Fossey SC, Kuroda S, Price JA, et al. Identification and characteriza- tion of PRKCBP1, a candidate RACK-like protein. Mamm Genome. 2000;11:919-25. doi:10.1007/s003350010174. PMID:11003709 · DOI
  40. Malovannaya A, Lanz RB, Jung SY, et al. Analysis of the human endogenous coregulator complexome. Cell. 2011;145:787-99. doi:10.1016/j.cell.2011.05.006. PMID:21620140 · DOI · Paper page
  41. Eberl HC, Spruijt CG, Kelstrup CD, et al. A map of general and spe- cialized chromatin readers in mouse tissues generated by label-free interaction proteomics. Mol Cell. 2013;49:368-78. doi:10.1016/j. molcel.2012.10.026. PMID:23201125 · DOI · Paper page
  42. Nishibuchi G, Shibata Y, Hayakawa T, et al. Physical and functional inter- actions between the histone H3K4 demethylase KDM5A and the nucleo- some remodeling and deacetylase (NuRD) complex. J Biol Chem. 2014;289:28956-70. doi:10.1074/jbc.M114.573725. PMID:25190814 · DOI
  43. Xia L, Huang W, Bellani M, et al. CHD4 Has Oncogenic Functions in Initiating and Maintaining Epigenetic Suppression of Multiple Tumor Suppressor Genes. Cancer Cell. 2017;31:653-68 e7. doi:10.1016/j.ccell.2017.04.005. · DOI
  44. Larsen DH, Poinsignon C, Gudjonsson T, et al. The chromatin- remodeling factor CHD4 coordinates signaling and repair after DNA damage. J Cell Biol. 2010;190:731-40. doi:10.1083/jcb.200912135. PMID:20805324 · DOI
  45. Smeenk G, Wiegant WW, Vrolijk H, et al. The NuRD chromatin- remodeling complex regulates signaling and repair of DNA damage. J Cell Biol. 2010;190:741-9. doi:10.1083/jcb.201001048. PMID:20805320 · DOI · Paper page
  46. Pan MR, Hsieh HJ, Dai H, et al. Chromodomain helicase DNA-bind- ing protein 4 (CHD4) regulates homologous recombination DNA repair, and its deficiency sensitizes cells to poly(ADP-ribose) poly- merase (PARP) inhibitor treatment. J Biol Chem. 2012;287:6764-72. doi:10.1074/jbc.M111.287037. PMID:22219182 · DOI
  47. Li DQ, Kumar R. Mi-2/NuRD complex making inroads into DNA- damage response pathway. Cell Cycle. 2010;9:2071-9. doi:10.4161/ cc.9.11.11735. PMID:20505336 · DOI
  48. Ohle C, Tesorero R, Schermann G, et al. Transient RNA-DNA Hybrids Are Required for Efficient Double-Strand Break Repair. Cell. 2016;167:1001-13 e7. doi:10.1016/j.cell.2016.10.001. · DOI
  49. Gaillard H, Aguilera A. Transcription as a Threat to Genome Integ- rity. Annu Rev Biochem. 2016;85:291-317. doi:10.1146/annurev- biochem-060815-014908. PMID:27023844 · DOI
  50. Aronica L, Kasparek T, Ruchman D, et al. The spliceosome-associ- ated protein Nrl1 suppresses homologous recombination-dependent R-loop formation in fission yeast. Nucleic Acids Res. 2016;44:1703- 17. doi:10.1093/nar/gkv1473. PMID:26682798 · DOI
  51. Barski A, Cuddapah S, Cui K, et al. High-resolution profiling of his- tone methylations in the human genome. Cell. 2007;129:823-37. doi:10.1016/j.cell.2007.05.009. PMID:17512414 · DOI · Paper page
  52. Nishioka K, Chuikov S, Sarma K, et al. Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation. Genes Dev. 2002;16:479-89. doi:10.1101/gad.967202. PMID:11850410 · DOI
  53. Zegerman P, Canas B, Pappin D, et al. Histone H3 lysine 4 methyla- tion disrupts binding of nucleosome remodeling and deacetylase (NuRD) repressor complex. J Biol Chem. 2002;277:11621-4. doi:10.1074/jbc.C200045200. PMID:11850414 · DOI
  54. Li X, Liu L, Yang S, et al. Histone demethylase KDM5B is a key regu- lator of genome stability. Proc Natl Acad Sci U S A. 2014;111:7096- 101. doi:10.1073/pnas.1324036111. PMID:24778210 · DOI
  55. Panagopoulos I, Micci F, Thorsen J, et al. Fusion of ZMYND8 and RELA genes in acute erythroid leukemia. PLoS One. 2013;8:e63663. doi:10.1371/journal.pone.0063663. PMID: 23667654 · DOI
  56. Cancer Genome Atlas Research N. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474:609-15. doi:10.1038/ nature10166. PMID: 21720365 · DOI · Paper page
  57. Basu M, Khan MW, Chakrabarti P, et al. Chromatin reader ZMYND8 is a key target of all trans retinoic acid-mediated inhibition of cancer cell proliferation. Biochim Biophys Acta. 2017;1860:450-9. doi:10.1016/j.bbagrm.2017.02.004. PMID: 28232094 · DOI
  58. Basu M, Sengupta I, Khan MW, et al. Dual histone reader ZMYND8 inhibits cancer cell invasion by positively regulating epithelial genes. Biochem J. 2017;474:1919-34. doi:10.1042/BCJ20170223. PMID: 28432260 · DOI
  59. Lai AY, Wade PA. Cancer biology and NuRD: a multifaceted chro- matin remodelling complex. Nat Rev Cancer. 2011;11:588-96. doi:10.1038/nrc3091. PMID: 21734722 · DOI
  60. Le Gallo M, O'Hara AJ, Rudd ML, et al. Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chro- matin-remodeling and ubiquitin ligase complex genes. Nat Genet. 2012;44:1310-5. doi:10.1038/ng.2455. PMID: 23104009 · DOI
  61. Teng YC, Lee CF, Li YS, et al. Histone demethylase RBP2 promotes lung tumorigenesis and cancer metastasis. Cancer Res. 2013;73:4711-21. doi:10.1158/0008-5472.CAN-12-3165. PMID: 23722541 · DOI
  62. Hou J, Wu J, Dombkowski A, et al. Genomic amplification and a role in drug-resistance for the KDM5A histone demethylase in breast cancer. Am J Transl Res. 2012;4:247-56. PMID: 22937203
  63. Sharma SV, Lee DY, Li B, et al. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell. 2010;141:69- 80. doi:10.1016/j.cell.2010.02.027. PMID: 20371346 · DOI · Paper page
  64. Rodriguez R, Miller KM. Unravelling the genomic targets of small molecules using high-throughput sequencing. Nat Rev Genet. 2014;15:783-96. doi:10.1038/nrg3796. PMID: 25311424 · DOI
  65. Dawson MA. The cancer epigenome: Concepts, challenges, and ther- apeutic opportunities. Science. 2017;355:1147-52. doi:10.1126/ science.aam7304. PMID: 28302822 · DOI · Paper page
  66. Brown JS, O'Carrigan B, Jackson SP, et al. Targeting DNA Repair in Cancer: Beyond PARP Inhibitors. Cancer Discov. 2017;7:20-37. doi:10.1158/2159-8290.CD-16-0860. PMID: 28003236 · DOI
  67. Jackson SP, Helleday T. DNA REPAIR. Drugging DNA repair Sci- ence. 2016;352:1178-9.
  68. Zacharioudakis E, Agarwal P, Bartoli A, et al. Chromatin Regulates Genome Targeting with Cisplatin. Angew Chem Int Ed Engl. 2017;56:6483-7. doi:10.1002/anie.201701144. PMID: 28474855 · DOI

Cited by

Sorted by citations

Authors
Gong, F., & Miller, K. M.
Affiliations
The University of Texas at Austin (US)
Corresponding author
Miller, Kyle M.
Venue
Cell Cycle
Published
2018-02-16
Volume
17
Issue
4
Pages
414-420
ISSN
  • 1538-4101 (ISSN-L)
  • 1551-4005
OpenAlex
W2794148770
Cited by
36
References
10
Citations by year
2026: 5 · 2025: 5 · 2024: 4 · 2023: 3 · 2022: 4 · 2021: 4 · 2020: 5 · 2019: 6
Type
journal article
Language
en
Open access
Locations
  • Cell Cycle (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • HHS | NIH | National Cancer Institute (NCI)s (CA201268)
  • American Cancer Society (RSG-16-042-01-DMC)
  • HHS | NIH | National Cancer Institute (CA198279)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords
ZMYND8, DNA damage response, DNA double-strand breaks, DNA repair, chromatin, histone acetylation, bromodomain proteins, histone methylation, histone demethylase, transcriptional regulation, genome maintenance, cancer
MeSH terms
Chromatin, DNA Repair, Humans, Neoplasm Metastasis, Neoplasms, Protein Processing, Post-Translational, Transcription, Genetic, Signal Transduction, Tumor Suppressor Proteins, DNA Breaks, Double-Stranded, Mi-2 Nucleosome Remodeling and Deacetylase Complex, Retinoblastoma-Binding Protein 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review